drugset / Trial / NCT06936709

Perioperative Colchicine for TKA

NCT06936709

RandomizedFactorialTriple-blindSupportive care

Summary

This study is a prospective, randomized, double-blinded, placebo-controlled study of the drug colchicine in the acute postoperative period for patients who are undergoing a total knee arthroplasty (TKA). Patients aged 18 years or older who are undergoing TKA will be invited to participate in the study. The primary endpoint of this study is to determine if colchicine, an anti-inflammatory medication commonly used for gout attacks, will decrease the postoperative pain of patients undergoing elective TKA.

Timeline

Start
2025-12-01
Primary completion
2026-01-01
Completion
2026-03-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Colchicine Small molecule 0.6 mg
Subject Colchicine Small molecule 1.8 mg

Indications